ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,889.84
0.96%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Inhibitor Therapeutics Inc (QB) (INTI)

  7. Inhibitor Therapeutics Inc (QB) (INTI) News

Inhibitor Therapeutics (QB) (INTI)

Inhibitor Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:INTI
DateTimeSourceHeadlineSymbolCompany
16/05/202418:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
16/05/202418:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
16/05/202418:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
16/05/202418:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
16/05/202418:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
13/05/202414:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INTIInhibitor Therapeutics Inc (QB)
14/12/202311:02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
18/10/202314:54Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
29/08/202320:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
29/08/202319:42Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
29/08/202319:33Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
11/08/202314:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INTIInhibitor Therapeutics Inc (QB)
31/05/202321:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
23/05/202317:50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:INTIInhibitor Therapeutics Inc (QB)
22/05/202320:45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202311:02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202300:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202300:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202300:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
15/05/202314:04Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
19/12/202222:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
14/11/202221:39Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
15/09/202222:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
13/05/202214:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
30/03/202214:02Edgar (US Regulatory)Annual Report (10-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
12/11/202114:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
14/05/202114:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
26/03/202113:03Edgar (US Regulatory)Annual Report (10-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
19/01/202118:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
06/01/202121:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:INTI

Your Recent History

LSE
REUG
Ve Circular Etf
LSE
GBCA
Etf L Cad S Gbp
BINA
ONEETH
Harmony
TSXV
SLS
Solaris Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved